|
|
|
|
Strategic Clinical Networks
|
|
Earlier this month we announced a change to the geography of the Greater Manchester, Lancashire and South Cumbria Strategic Clinical Networks and the consequent formation of the Greater Manchester and East Cheshire Strategic Clinical Networks (GMEC SCNs). The GMEC SCNs going forward will work as an integrated part of Greater Manchester Academic Health Science Network, and the team will be joining us at our offices in Citylabs.
Read the full story here
|
|
|
Familial Hypercholesterolaemia – Update
We have recently been developing a business case to support our work improving the diagnosis and care of Familial Hypercholesterolaemia (FH). The project is moving forwards, and the document was recently submitted to the regional Heads of Commissioning (HoC) for comment. On a suggestion from the HoC group we may also be looking at submitting the case to the Greater Manchester Transformation Board and Mike Burrows (GM AHSN Managing Director) is scheduled to meet with relevant colleagues to discuss this option.
The GM AHSN Senior Management Team (SMT) has considered the case and provided helpful feedback on the health economics aspects of the case. It is expected this will be updated in the next few weeks.
We are also in discussions with industry colleagues around formulating a joint working arrangement to meet some of the requirements of the service. The main purpose being to ensure we gain best value for the GM Health Economy in meeting the financial and practical requirements for any new service.
We are pleased with the progress made so far, and we will endeavour to provide updates throughout the project. For further information please contact Cara Afzal or Ruth Eatough.
|
|
|
Patient Activation Measure (PAM) tool
GM AHSN is currently supporting its member organisation, Heywoood, Middleton and Rochdale (HMR) CCG, in applying for free access to a tool which clinicians can use to support patients to better manage their own health and wellbeing.
HMR’s Long Term Conditions Test Bed Programme is one of only 7 national ‘test-bed’ sites, awarded by NHS England earlier this year. The CCG is working with innovation partners Verily Life Sciences (formerly Google Life Sciences) and MSD (Merck, Sharp & Dohme Ltd) on a two-year pilot scheme in the borough; allowing a project team to analyse non identifiable patient and other data – flagging up patients who are at risk of developing long term conditions, to their GPs, at an earlier stage.
According to NHS England:
“The Patient Activation Measure (PAM) is a validated, commercially licensed tool and has been extensively tested with reviewed findings from a large number of studies, as evidenced in the Kings Fund report. It helps to measure the spectrum of skills, knowledge and confidence in patients and captures the extent to which people feel engaged and confident in taking care of their condition.”
HMR plan to include PAM as part of health coaching modules to ensure identified patients are confident to self-care with the aid of technology. Their approach will be supported by data sources that will provide scientifically robust selection and decision support criteria.
PAM would allow primary care clinicians, social care and/or voluntary sector staff to determine levels of patient engagement. This would enable the CCG and partners (including Rochdale Borough Council) to design care pathways and intervention services to support patients to self-manage their conditions and modify lifestyles to prevent ill health.
HMR CCG’s application for a PAM license was submitted last week, and we expect to have decision by early June.
|
|
|
|
Make May Purple is the Stroke Association’s annual Stroke Awareness Month, marked by a range of purple-themed events and activities. As GM AHSN is working on stroke prevention, through our projects improving AF detection and treatment, we have been getting involved in some of the fun!
On Wednesday 18th May, we had a visit in the office from Stroke Association North-West mascot ‘Barry the Baton’, who is being passed around the region raising awareness of stroke. We also took part in Manchester’s ‘Step out for Stroke’ event, in Whitworth Park, on Tuesday 24th May.
|
|
|
New Innovation Funds
This week saw the launch of three new Innovation Funds, available for academics, NHS innovators and SMEs working to improve healthcare outcomes.
Having supported over 200 local SMEs with our Innovation Nexus platform in the past 18 months, we have developed the Innovation Funds with consideration for the challenges of bringing a new product or service to the healthcare market.
The GM AHSN Innovation Funds will support the introduction and adoption of needs-led, evidence-based innovations into the healthcare system within the GM AHSN footprint. This will improve the health of citizens, whilst promoting economic development and wealth creation through the growth of local businesses and jobs.
Read more on our website.
|
|
|
Ask the buyer
Earlier in the month we held a successful ‘Ask the buyer’ event with our partners TRUSTECH at our base in Citylabs. The event was well attended by representatives from local SMEs, and by NHS staff responsible for purchasing at North West hospital trusts.
Look at our Storify for more details.
|
|
|
Following a successful visit to China in spring 2016, staff from GM AHSN are soon to be travelling out to India as part of a UKTI trade mission. On behalf of the organisations associated with the AHSN, our intention is to showcase Greater Manchester as a “Connected Healthy City” illuminating and articulating our UK and world leading clinical services and systems, clinical research, informatics and our leading edge approach to integrated and now devolved health and social care strategy and decision making.
We will be showcasing Greater Manchester’s achievements, track record and potential in world class life sciences, thought leadership and research, academic health sciences, digital maturity, implementation and system management in keeping with our position as Europe’s largest single site clinical academic campus. This is a fantastic opportunity to demonstrate how Greater Manchester has interwoven NHS systems services and ethos with business growth and prosperity.
|
|
|
|
Greater Manchester healthcare achieves world first with initial results of Salford Lung Study
Healthcare professionals from eight organisations across Greater Manchester have collaborated to deliver the initial results of the Salford Lung Study (SLS). The study involved over 2,800 consenting patients, supported by 80 GP practices and 130 pharmacies in Salford and the surrounding Greater Manchester area.
This ground-breaking study, sponsored by GSK, examined the safety and effectiveness of a new treatment for chronic obstructive pulmonary disease (COPD). This was delivered in partnership with NorthWest EHealth (NWEH), The University of Manchester, Salford Royal NHS Foundation Trust, CK Aspire, Salford CCG, University Hospital South Manchester, South Manchester CCG and NIHR Clinical Research Network: Greater Manchester.
Read the full story on our website.
|
|
|
North of England ImPaCT Conference
Thursday 9th June 2016
Manchester Conference Centre, M1 3BB
This event will focus on inspiring and enabling health care workers to drive excellence in healthcare provision through quality improvement, good leadership and a better understanding of human factors.
Delegates will have the opportunity to:
- Learn about local improvement projects and gain Quality Improvement skills
- Hear about human factors and the impact it can have on care provision
- Engage in simulation sessions, focusing on the impact leadership and human factors can have on working relationships and patient care
- Find out more about the FMLM Leadership and Management Standards for Medical Professionals
- Attend the Speed Presentations to hear from the winners of the poster competition
- Hear the opinions of Local and Regional Healthcare Leaders on Leadership, Patient Safety, Quality Improvement and Human Factors
Register now
Manchester Pharmacy School – Pharmacy Practice Research & Education Showcase Event
Wednesday 22nd June 2016
University of Manchester, Stopford Building, Lecture Theatre 3
2.30pm-5.30pm
Through a series of presentations, posters and networking time, this afternoon event will showcase Manchester Pharmacy School’s research in collaboration with pharmacy practice partners and its innovative clinical postgraduate taught programmes. Presentations will include:
- Refer-to-Pharmacy scheme: early outcomes
- MyPrescribe: an audit and feedback method for reducing prescribing errors
- TECHMED: pharmacy technician supported medicines administration
- Postgraduate taught programmes: emergency department pharmacist training, MClinRes research training, flexible learning clinical diploma
This event is free and is suitable for pharmacists in all sectors of practice.
Register before 18 th June at: http://www.eventbrite.co.uk/o/paula-rosson-10512985342
AQuA Events 2016/17
Our partners at AQuA have released their 2016/17 events prospectus. As GM AHSN members you are eligible to attend AQuA events, please feel free to look over this year’s offering.
HealthTech Women Manchester
Tuesday 28 th June 2016
EY, 100 Barbirolli Square, Manchester, M2 3EY
5.30-8pm
Following our successful “Launch in the North” event in Leeds, HealthTech Women UK is moving the conversation to the North West evening event in Manchester this June.
This session will be chaired by Rachel Dunscombe, CIO at Salford Royal Foundation Trust and panellists include:
• Sarah Thew - Innovation & User Experience Manager, GM AHSN
• Karen McLaughlin - European Operations Director, CSC
• Phillipa Winter - Joint CIO & CCIO, Bolton NHS Foundation Trust
Register online
|
|
|
|
|
|
|
|
|
|
Earlier this month the AHSN managing directors and chief executives met with Ian Dodge, who is NHS England’s director with executive responsibility for England’s 15 Academic Health Science Networks.
